Institutional investors hold a majority ownership of ZTS through the 95.70% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2016, these large investors purchased a net $21.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 10.7 Million shares of Zoetis Inc
MASSACHUSETTS FINANCIAL SERVICES... Bought 4.7 Million shares of Zoetis Inc
ALLIANCEBERNSTEIN LP Bought 2.5 Million shares of Zoetis Inc